Correction to: Nature Cancer https://doi.org/10.1038/s43018-019-0003-0, published online 9 December 2019.
In the version of this article initially published, the labels above the bottom two plots of Fig. 5e (PAK4 KO isotype (bottom left) and PAK4 KO anti-PD-1 (bottom right)) were incorrect. The correct labels are PAK4 WT isotype (bottom left) and PAK4 WT anti-PD-1 (bottom right). The legend for Fig. 5e also identified one group incorrectly (‘B16 PAK4 isotype’). The correct list of groups is ‘B16 PAK4 KO isotype; B16 PAK4 KO anti-PD-1; B16 WT isotype; and B16 WT anti-PD-1’. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abril-Rodriguez, G., Torrejon, D.Y., Liu, W. et al. Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy. Nat Cancer 1, 264 (2020). https://doi.org/10.1038/s43018-020-0025-7
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s43018-020-0025-7
